| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | NanoVibronix feeds into new focus on ENvue enteral system with rebrand | 2 | FiercePharma | ||
| Fr | NanoVibronix to rebrand as ENvue Medical, trade under FEED symbol | 3 | Investing.com | ||
| ENVUE MEDICAL Aktie jetzt für 0€ handeln | |||||
| Fr | NanoVibronix, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and 'FEED' | 70 | Business Wire | New ticker symbol, "FEED" will begin trading on the Nasdaq at the open of the market on December 12, 2025
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) ("NanoVibronix" or the "Company")... ► Artikel lesen | |
| 05.12. | NanoVibronix, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 19.11. | NanoVibronix to rebrand with focus on ENvue tech, seek alternatives for legacy products | 1 | MassDevice | ||
| 19.11. | NanoVibronix issues letter to shareholders | 1 | Seeking Alpha | ||
| 19.11. | NanoVibronix to rebrand as ENvue Medical, focuses on feeding tube tech | 1 | Investing.com | ||
| 19.11. | NanoVibronix, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.11. | NanoVibronix, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 30.10. | NanoVibronix, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 17.09. | NanoVibronix, Inc. - 8-K, Current Report | 15 | SEC Filings | ||
| 16.09. | NanoVibronix prices $2M registered direct offering | 14 | Seeking Alpha | ||
| 16.09. | NanoVibronix raises $2 million in registered direct offering | 1 | Investing.com | ||
| 16.09. | NanoVibronix stock tumbles after share resale registration | 1 | Investing.com | ||
| 15.09. | NanoVibronix files to sell 1.35M shares of common stock for holders | 1 | Seeking Alpha | ||
| 15.09. | NanoVibronix Stock Soars 72% On Patent Grant | 1 | RTTNews | ||
| 15.09. | NanoVibronix stock soars after securing new U.S. patent for medical guidance system | 6 | Investing.com | ||
| 15.09. | NanoVibronix receives patent for medical device positioning technology | 13 | Investing.com | ||
| 04.09. | NanoVibronix Shares Slide 10% Despite Patent Grant | 1 | RTTNews |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 44,030 | +0,94 % | Starke Kursanstiege - AJN Resources, Delivery Hero, Siemens Healthineers | Ein massiver Stellenabbau betrifft nicht nur die deutsche Wirtschaft, auch in der Schweiz sind Umstrukturierungen erforderlich, um sich den Marktgegebenheiten anzupassen. Nach der überstürzten Übernahme... ► Artikel lesen | |
| BECTON DICKINSON | 169,75 | -0,82 % | Dividendenbekanntmachungen (08.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGRICULTURAL BANK OF CHINA LTD ADR US00850M1027 0,4197 USD 0,3605 EUR ALPHABET INC CDR CA02080K1049 0,0339 CAD 0,0211 EUR ALPHABET... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,022 | +9,90 % | NuGen Medical: Kurs explodiert nach wichtiger News! | ||
| SPINEWAY | 0,145 | +1,39 % | Spineway: Revenue growth in the third quarter | Ecully, October 14, 2025 - 6:30 p.m. SPINEWAYRevenue growth in the third quarter In thousands of euros20252024Change as a %Q3 revenue3,0452,575 +18%Q2 revenue2,7453,465-21% Q1 revenue2,8283,070-8%9M... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| LIFEWARD | 0,670 | -4,15 % | Lifeward Ltd. Reports Third Quarter 2025 Financial Results | Record quarter of ReWalk systems placed for Medicare beneficiaries since fee schedule established Ongoing efficiency initiatives drive 16% year-over-year decrease in quarterly cash burn and 27%... ► Artikel lesen | |
| NUWELLIS, INC | 2,280 | -7,32 % | Nuwellis, Inc.: Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings | ||
| LOGICMARK | - | - | LogicMark, Inc. Announces Third Quarter 2025 Results | LOUISVILLE, Ky., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc.?(OTC: LGMKD) (the Company), a provider of personal safety and emergency response systems (PERS), health communications devices, and... ► Artikel lesen | |
| GLUCOTRACK | 5,830 | -0,68 % | GlucoTrack, Inc.: Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights | On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device... ► Artikel lesen | |
| BONE BIOLOGICS | 2,010 | +5,79 % | Bone Biologics Corp - S-8, Securities to be offered to employees in employee benefit plans | ||
| MANGOCEUTICALS | 1,130 | 0,00 % | MANGOCEUTICALS, INC. - 8-K, Current Report | ||
| FRESENIUS MEDICAL CARE | 40,130 | +0,53 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 47,560 | -0,73 % | AKTIEN IM FOKUS: Medizintechnikwerte von Exane bewegt - 'Zweigeteiltes 2026' | FRANKFURT (dpa-AFX) - Die Aktien von Siemens Healthineers und Sartorius haben am Mittwoch nach einer Studie von Exane BNP Paribas zum europäischen Medizintechniksektor unterschiedliche Richtungen eingeschlagen.... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,360 | -0,31 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 40,580 | +1,45 % | EQS-Adhoc: Carl Zeiss Meditec AG: Beendigung der Vorstandstätigkeit von Maximilian Foerst zum 31.12.2025 und interimistische Übernahme des Vorstandsvorsitzes durch Andreas Pecher zum 01.01.2026 | EQS-Ad-hoc: Carl Zeiss Meditec AG / Schlagwort(e): Personalie
Carl Zeiss Meditec AG: Beendigung der Vorstandstätigkeit von Maximilian Foerst zum 31.12.2025 und interimistische Übernahme... ► Artikel lesen |